Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Home Depot (NYSE:HD) Trading Up 1.9% – Should You Buy?
The Home Depot, Inc. (NYSE:HD – Get Free Report) rose 1.9% on Friday . The company traded as high as...
IDEX (NYSE:IEX) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
IDEX (NYSE:IEX – Get Free Report) had its price objective lifted by equities research analysts at Royal Bank of Canada...
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Average Rating of “Buy” from Brokerages
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten analysts...
Critical Analysis: Cenntro (NASDAQ:CENN) & NWTN (NASDAQ:NWTN)
Insider and Institutional Ownership 0.2% of NWTN shares are held by institutional investors. 46.1% of NWTN shares are held by...
TKO Group Holdings, Inc. (NYSE:TKO) Receives Consensus Rating of “Moderate Buy” from Brokerages
TKO Group Holdings, Inc. (NYSE:TKO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the...
Atmos Energy Co. (NYSE:ATO) Shares Sold by Holocene Advisors LP
Holocene Advisors LP decreased its holdings in shares of Atmos Energy Co. (NYSE:ATO – Free Report) by 87.9% in the...